Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.

Autor: Doheny D; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Sirkisoon S; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Carpenter RL; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine-Bloomington, JH 308 1001 E. 3rd St., Bloomington, IN, 47405, USA., Aguayo NR; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Regua AT; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Anguelov M; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Manore SG; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Arrigo A; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Jalboush SA; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Wong GL; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Yu Y; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Wagner CJ; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Chan M; Wake Forest Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Ruiz J; Wake Forest Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Department of Hematology and Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Thomas A; Wake Forest Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Department of Hematology and Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Strowd R; Wake Forest Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Department of Neurology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Lin J; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA., Lo HW; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA. hlo@wakehealth.edu.; Wake Forest Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA. hlo@wakehealth.edu.
Jazyk: angličtina
Zdroj: Oncogene [Oncogene] 2024 Jun; Vol. 43 (23), pp. 1811.
DOI: 10.1038/s41388-024-03046-9
Databáze: MEDLINE